Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | WISH | Class A Common Stock | Options Exercise | $0 | +116K | +66.54% | $0.00 | 290K | May 15, 2022 | Direct | F1 |
transaction | WISH | Class A Common Stock | Tax liability | -$161K | -104K | -36.04% | $1.54 | 185K | May 15, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | WISH | Restricted Stock Unit | Options Exercise | $0 | -116K | -8.33% | $0.00 | 1.27M | May 15, 2022 | Class A Common Stock | 116K | $0.00 | Direct | F1, F3, F4 |
Pai Liu is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Id | Content |
---|---|
F1 | On May 17, 2022, the Reporting Person filed a Form 4 that inadvertently stated the incorrect number of shares settled and withheld, and those numbers are corrected in this Form 4. |
F2 | Represents the number of shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the settlement of Restricted Stock Units ("RSUs") reported on the original Form 4, as adjusted for the correction noted in this Form 4 filing. |
F3 | This reported transaction represents the settlement of RSUs vested as of May 15, 2022. |
F4 | Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. Subject to the reporting person's continuous service, 1/12th of the RSUs will vest on a quarterly basis beginning on May 15, 2022 (with all quarterly vesting events occurring on a "Company Vesting Date" of February 15, May 15, April 15, or November 15). Vested RSUs will settle on or following the vesting date, but in any event within 60 days following the vesting date (unless the Reporting Person and the Company have agreed in writing to a later settlement date pursuant to the procedures the Company may prescribe at its discretion). |